Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Preoperative Sedation in Children
NCT04200235Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jan 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in preoperative sedation (4 arms), sponsored by Hengrui. Primary endpoint: Maximum Plasma Concentration (Cmax). Started Jan 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
preoperative sedation
Beyond the preview
Go deeper on NCT04200235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04200235.